C4 Therapeutics (CCCC) Revenue & Revenue Breakdown
C4 Therapeutics Revenue Highlights
Latest Revenue (Y)
$20.76M
C4 Therapeutics Revenue by Period
C4 Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $20.76M | -33.25% |
| 2022-12-31 | $31.10M | -32.08% |
| 2021-12-31 | $45.78M | 37.93% |
| 2020-12-31 | $33.20M | 55.25% |
| 2019-12-31 | $21.38M | 10.42% |
| 2018-12-31 | $19.36M | - |
C4 Therapeutics generated $20.76M in revenue during NA 2023, up -33.25% compared to the previous quarter, and up 107.19% compared to the same period a year ago.
C4 Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $7.24M | 39.81% |
| 2024-12-31 | $5.18M | -66.30% |
| 2024-09-30 | $15.36M | 27.95% |
| 2024-06-30 | $12.01M | 295.06% |
| 2024-03-31 | $3.04M | -6.81% |
| 2023-12-31 | $3.26M | -70.55% |
| 2023-09-30 | $11.07M | 315.62% |
| 2023-06-30 | $2.66M | -29.13% |
| 2023-03-31 | $3.76M | 31.71% |
| 2022-12-31 | $2.85M | -57.74% |
| 2022-09-30 | $6.75M | -51.18% |
| 2022-06-30 | $13.83M | 80.74% |
| 2022-03-31 | $7.65M | -61.88% |
| 2021-12-31 | $20.08M | 136.21% |
| 2021-09-30 | $8.50M | -13.10% |
| 2021-06-30 | $9.78M | 31.71% |
| 2021-03-31 | $7.43M | -10.12% |
| 2020-12-31 | $8.26M | -2.19% |
| 2020-09-30 | $8.45M | -12.65% |
| 2020-06-30 | $9.67M | 41.87% |
| 2020-03-31 | $6.82M | -16.97% |
| 2019-12-31 | $8.21M | 53.04% |
| 2019-09-30 | $5.36M | 37.42% |
| 2019-06-30 | $3.90M | - |
| 2019-03-31 | $3.90M | - |
C4 Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.